Referanser

Ikke-småcellet lungekarsinom

1. Gridelli, C., Langer, C., Maione, P., Rossi, A., Schild, S.E. 2007. Lung cancer in the elderly. J Clin Oncol 25:1898-1907.
2. Vansteenkiste, J. 2006. Second-line therapeutic options in non-small-cell lung cancer. Lung Cancer 54 Suppl 2:S15-18. 
3. Winton, T., Livingston, R., Johnson, D., Rigas, J., Johnston, M., Butts, C. et al. 2005. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med 352:2589-2597.
4. Shepherd, F.A., Rodrigues Pereira, J., Ciuleanu, T., Tan, E.H., Hirsh, V., Thongprasert, S. et al. 2005. Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med 353:123-132.
5. Rusch, V.W., Giroux, D.J., Kraut, M.J., Crowley, J., Hazuka, M., Winton, T. et al. 2007. Induction chemoradiation and surgical resection for superior sulcus non-small-cell lung carcinomas: long-term results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160). J Clin Oncol 25:313-318.
6. Graham, M.V., Purdy, J.A., Emami, B., Harms, W., Bosch, W., Lockett, M.A., et al. 1999. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 45:323-329.
7. Giaccone, G. 2005. Epidermal growth factor receptor inhibitors in the treatment of non-small-cell lung cancer. J Clin Oncol 23:3235-3242.
8. Lally, B.E., Zelterman, D., Colasanto, J.M., Haffty, B.G., Detterbeck, F.C., Wilson, L.D. 2006. Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database. J Clin Oncol 24:2998-3006.
9. Sundstrøm S, Bremnes R, Aasebø U, Aamdal S, Hatlevoll R, Brunsvig P, Johannessen DC, Klepp O, Fayers PM, Kaasa S. Hypofractionated palliativ radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carsinoma is comparable to standard fractionation for symptom control and survival: a national phase III trail. J Clin Oncol. 2004 Mar 1; 22(5):801–10.

   Småcellet lungekarsinom

10. Tiseo, M., Ardizzoni, A. 2007. Current status of second-line treatment and novel therapies for small cell lung cancer. J Thorac Oncol 2:764-772.
11. Blackstock, A.W.,Govindan, R. 2007. Definitive chemoradiation for the treatment of locally advanced non small-cell lung cancer. J Clin Oncol 25:4146-4152.
12. Turrisi, A.T., 3rd, Kim, K., Blum, R., Sause, W.T., Livingston, R.B., Komaki, R., et al 1999. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 340:265-271.
13. Auperin, A., Arriagada, R., Pignon, J.P., Le Pechoux, C., Gregor, A., Stephens, R.J., et al. 1999. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med 341:476-484.
14. Slotman, B., Faivre-Finn, C., Kramer, G., Rankin, E., Snee, M., Hatton, M., et. al. 2007. Prophylactic cranial irradiation in extensive small-cell lung cancer. N Engl J Med 357:664-672.
15. Evans, W.K., Shepherd, F.A., Feld, R., Osoba, D., Dang, P., Deboer, G. 1985. VP-16 and cisplatin as first-line therapy for small-cell lung cancer. J Clin Oncol 3:1471-1477.

    Røyking

16. Helland A., Brustugun O.T. 2009. Lungekreft hos røykere og aldri-røykere. Tidsskr Nor Laegeforen. 129:1859-62. 
17. Gandini S, Botteri E, Iodice S. Boniol M, Lowenfels A.B, Maisonneuve P, and Boyle, P. Tobacco smoking and cancer: A meta-analysis. Int J Cancer. 2008 Jan 1; 122(1):155–64

    Stadieinndeling

18. Brambilla, E., Travis, W.D., Colby, T.V., Corrin, B., Shimosato, Y. 2001. The new World Health Organization classification of lung tumours. Eur Respir J 18:1059-1068.
19. Goldstraw, P., Crowley, J., Chansky, K., Giroux, D.J., Groome, P.A., Rami-Porta, R., et al. 2007. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2:706-714.

    Prognose

20. Sagerup CM, Småstuen M, Johannesen TB, Helland A, Brustugun OT. Thorax. 2011 Apr;66(4):301-7. Epub 2011 Jan 2.

    Diagnostikk/screening

21. Chin, R., Jr., Ward, R., Keyes, J.W., Choplin, R.H., Reed, J.C., Wallenhaupt, S., et al. 1995. Mediastinal staging of non-small-cell lung cancer with positron emission tomography. Am J Respir Crit Care Med 152:2090-2096.
22. Bach, P.B., Jett, J.R., Pastorino, U., Tockman, M.S., Swensen, S.J., Begg, C.B. 2007. Computed tomography screening and lung cancer outcomes. Jama 297:953-961.
23. Henschke, C.I., Yankelevitz, D.F., Libby, D.M., Pasmantier, M.W., Smith, J.P., Miettinen, O.S. 2006. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 355:1763-1771.

    Kirurgi

24. Martini, N., and Flehinger, B.J. 1987. The role of surgery in N2 lung cancer. Surg Clin North Am 67:1037-1049.
25. Ginsberg, R.J., and Rubinstein, L.V. 1995. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 60:615-622; discussion 622-613.
26. Alexander, E., 3rd, Moriarty, T.M., Davis, R.B., Wen, P.Y., Fine, H.A., Black, P.M., et al. 1995. Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastases. J Natl Cancer Inst 87:34-40.